Literature DB >> 19266320

Ex vitro expansion of human placenta-derived mesenchymal stem cells in stirred bioreactor.

Yanqiu Yu1, Kun Li, Chunyu Bao, Tianqing Liu, Yunan Jin, Haiqin Ren, Wei Yun.   

Abstract

The high demand of human placenta-derived mesenchymal stem cells (hPDMSCs) for therapeutic applications requires reproducible production of large numbers of well-characterized cells under well-controlled conditions. However, no method for fast hPDMSCs proliferation has yet been reported. In the present study, the feasibility of using a stirred bioreactor system to expand hPDMSCs was examined. hPDMSCs were cultured either in stirred bioreactors or in tissue culture flasks (T-flasks) for 5 days. Total cell density and several parameters of physical microenvironments were monitored in the two culture systems every 24 h. The maintenance of the antigenic phenotype of hPDMSCs before and after culturing in the stirred bioreactor system was cytometrically assessed. Data suggested that the physical microenvironment in the stirred bioreactors was much more favorable than that of the T-flasks. At the end of 144 h culturing, the total cell number was increased 1.73 times from the T-flasks to the stirred bioreactors. In addition, hPDMSCs could maintain their antigenic phenotype when cultured in stirred bioreactors. These results provide the initial assessment for large-scale hPDMSCs production using suspension culture bioreactors.

Entities:  

Mesh:

Year:  2009        PMID: 19266320     DOI: 10.1007/s12010-009-8556-5

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  6 in total

Review 1.  The current status of engineering myocardial tissue.

Authors:  Runqian Sui; Xiaobo Liao; Xinmin Zhou; Qi Tan
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

2.  The use of multidimensional image-based analysis to accurately monitor cell growth in 3D bioreactor culture.

Authors:  Marc-Olivier Baradez; Damian Marshall
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

3.  Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway.

Authors:  Juliana A Passipieri; Tais H Kasai-Brunswick; Grazielle Suhett; Andreza B Martins; Guilherme V Brasil; Dilza B Campos; Nazareth N Rocha; Isalira P Ramos; Debora B Mello; Deivid C Rodrigues; Beatriz B Christie; Bernardo J Silva-Mendes; Alex Balduíno; Renato M Sá; Laudelino M Lopes; Regina C Goldenberg; Antonio C Campos de Carvalho; Adriana B Carvalho
Journal:  Stem Cell Res Ther       Date:  2014-08-21       Impact factor: 6.832

4.  Conditioned medium from primary cytotrophoblasts, primary placenta-derived mesenchymal stem cells, or sub-cultured placental tissue promoted HUVEC angiogenesis in vitro.

Authors:  Jun Wei; Yanqiu Yu; Haiying Ma; Shenglu Jiang; Lili Du; Jinfang Liu; Xiaoyan Xu; Xiaomei Lu; Ling Ma; Hua Zhu
Journal:  Stem Cell Res Ther       Date:  2021-02-17       Impact factor: 6.832

5.  Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection.

Authors:  Simone Avanzi; Valerio Leoni; Antonella Rotola; Francesco Alviano; Liliana Solimando; Giacomo Lanzoni; Laura Bonsi; Dario Di Luca; Cosetta Marchionni; Gualtiero Alvisi; Alessandro Ripalti
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

6.  Large scale expansion of human umbilical cord cells in a rotating bed system bioreactor for cardiovascular tissue engineering applications.

Authors:  Anne Reichardt; Bianca Polchow; Mehdi Shakibaei; Wolfgang Henrich; Roland Hetzer; Cora Lueders
Journal:  Open Biomed Eng J       Date:  2013-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.